Board Approved A 1-For-3,000 Reverse Split Of Company's Ordinary Shares
23/12/2025 22:50
Dec 23 (Reuters) - Can Fite Biopharma Ltd CANF.TA: CAN FITE BIOPHARMA LTD - BOARD APPROVED A 1-FOR-3,000 REVERSE SPLIT OF COMPANY'S ORDINARY SHARES CAN FITE BIOPHARMA LTD - ADS RATIO CHANGE TO ONE (1) ADS REPRESENTING TWO (2) ORDINARY SHARES Source text: ID:nGNX8QZ74x Further company coverage: CANF.TA ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Can Fite Biopharma
See all newsBrief: Following Positive Phase 2A Pancreatic Cancer Data, Can-Fite Advances Namodenoson Into Phase 2B Combination Study With Immunotherapy
Can-Fite Biopharma surges as pancreatic cancer drug meets main goal in study
Brief: Can-Fite Completes Patient Enrollment In Phase 2A Pancreatic Cancer Study Of Namodenoson
Board Approved A 1-For-3,000 Reverse Split Of Company's Ordinary Shares
Brief: Can-Fite Provides Update On Clinical And Financial Status